We have determined the expression profiles of cdh7, and the related cdh20 during development. Both transcripts are found in the adult brain, but only cadherin-20 mRNA was detected during embryogenesis. In mouse embryos, cadherin-20 is synthesized by the forebrain, anterior neural ridge, developing visual system, primitive external granular layer of the cerebellum and a subset of neural crest cells likely to develop into melanoblasts. We found that the other embryonic tissues in which cadherin-20 was synthesized depended on genetic background. Melanoma cell lines contained transcripts for cadherin-7 but not for cadherin-20. The majority of the malignant melanoma cell lines produced N-cadherin (N-Cad) and/or cadherin-7 whereas melanocyte cell lines did not. The converse was observed for E-cadherin (E-Cad). Our data suggest that during development cadherin-20 is a key player in compartmentalization of the neural tube and establishment of neural circuitry. Finally, during oncogenesis, cadherin-7, N-cad and E-cad could be used as an efficient marker set for melanoma.
Introduction
The cadherin proteins (Cad) constitute an evolutionary ancient superfamily of Ca 2 þ -dependent cell adhesion molecules (CAM) (Takeichi, 1991) . Several 100 genes encoding molecules with the characteristic structural motif of the cad extracellular (EC) domain have been described in vertebrates and invertebrates (Tepass et al., 2000) . The diversity of the sequences obtained has led to the classification of cadherin genes into types I and II (Nollet et al., 2000) . Homophilic binding affinity generates an adhesive repertoire such that cells or neurites presenting a particular cadherin 'code' adhere to one another. Stable and strong cell adhesion is promoted by the anchorage of cadherin to the cytoskeletal actin network by catenin adaptors (Gumbiner, 2000) . Dysfunction or dysregulation of any component of the cadherin-catenin complex (CCC) dramatically affects embryogenesis and leads to pathogenesis (Tepass et al., 2000) . For example, the E-cadherin (E-cad) gene (cdh1) is thought to be a potent invasion suppressor gene (Christofori and Semb, 1999; Mareel and Leroy, 2003) . It may be functionally inactivated during carcinoma progression by a loss of heterozygosity, transcriptional repression or CpG island hypermethylation (Mareel and Leroy, 2003) . E-cad loss is compensated by production of a type I (N-cadherin (N-Cad) ¼ Cdh2) or II (cadherin-11 ¼ Cdh11) nonepithelial cadherins, in breast and prostate cancer cell lines, respectively (Tomita et al., 2000) . The ectopic expression of N-cad or a specific spliced form of cadherin-11 can induce an invasive phenotype (Hazan et al., 2000; Feltes et al., 2002) .
Cutaneous melanoblasts and their differentiated derivatives, melanocytes, are responsible for all cutaneous and pelage pigmentation. Melanocytes of all axial levels arise from neural crest cells (NCC) (Le Douarin and Kalcheim, 1999) . After neural tube delamination, an array of signaling pathways induce the transcription factor Mitf within a limited number of NCC, establishing a program of melanoblast-specific gene expression (Goding, 2000) . Specific Cads are induced and repressed sequentially during NCC development, as shown in chicken and mouse embryos (Pla et al., 2001) . In chicken, immediately before and after neural tube dissociation, neural crest cells lose N-cad and produce Cad6B (Nakagawa and Takeichi, 1995 Takeichi, , 1998 . Then NCC emigrating from the neural tube produce Cad7, in addition to Cad6B (Nakagawa and Takeichi, 1995 Takeichi, , 1998 . In the mouse, the pattern of cadherin expression remains unclarified at early stages of melanoblast development. In particular, as mouse cdh7 is not cloned, the expression profile of the cdh7 ortholog is totally unknown. However, later aspects of melanocyte development are better known in the mouse. For instance, dermal melanoblasts begin to express E-cad before penetrating the epidermis. After colonization of the epidermis, melanoblasts synthesize large amounts of E-cad and small amounts of P-cad, thereby mimicking the in situ cadherin code of the surrounding keratinocytes (Jouneau et al., 2000; Nishimura et al., 1999) .
Metastatic cutaneous melanoma is a highly aggressive, poorly differentiated tumor, refractory to therapy and rapidly increasing in incidence. It develops in discrete, well-characterized histological stages from melanocyte precursors. The importance of E-and Ncad in melanocyte transformation was previously documented, but other CAMs should be involved in this process (Li and Herlyn, 2000) .
Here, we cloned and analysed during melanocyte genesis and in melanoma two closely related mouse cadherins, cdh7 and cdh20. The genomic structure and spatio-temporal expression profiles of these two cadherins were determined during mouse embryogenesis and melanocyte transformation. Cad20 appears to be more influential than Cad7 in melanocyte development whereas Cad7 is more important in transformation.
Results

Cloning and sequence analysis of mouse cad-7 cDNA
The mouse Cad7 cDNA (cdh7) was cloned by interspecies reverse transcriptase (RT)-PCR approach and screening of a mouse brain cDNA library, followed by manual contig assembly. The first 'ATG' in the 3.4 kb cDNA (position 205) is preceded (183 bp upstream) by an in-frame 'TAG' stop codon. The longest putative open reading frame (2358 bp, encoding 785 amino acids) is generated if translation starts at this site. This putative initiator codon does not conform to the Kozak vertebrate consensus context (GCCRCCaugG), but neither do those of the chicken and human cdh7 cDNAs (all three are AAAAAGaugA). The first termination codon encountered (position 2560) is closely followed by stop codons in all three frames, together with a consensus polyadenylation sequence (AATAAA) (position 3189).
The predicted Cad7 precursor protein is similar in topology and modular structure to most Cad: signal peptide, prepeptide and five tandemly repeated 110-amino-acid EC domains, followed by a transmembrane and an intracellular cytoplasmic domain (Figure 1a ). The predicted primary sequence is 97.7% identical to that of human Cad7. A putative 27-amino-acid signal peptide (aa 1-27, cleavage site MSQAkELPR) is immediately followed by a 20-amino-acid prepeptide (aa 28-47) terminating in a convertase recognition motif: RX(K/R)RkX (Posthaus et al., 2003) . Endoproteolytic cleavage of this prepeptide by convertase metalloproteases is essential for the adhesive function of mature Cad. A large ectodomain (aa 48-605) protrudes outside the cell that and mediates adhesion. The 'HAV' sequence of E-cad involved in trans adhesive contact is replaced by QAL' in both Cad7 (aa 123-125) and Cad20. The first four EC domains are named EC1 to 4 and the fifth is named MPED (membrane-proximal EC domain). The EC domains contain motifs (DXD, LDRE, DXNDN), which co-ordinate Ca 2 þ ions be- ctn and presenilin-1 may bind to the p120BD of Cad7. The E-cad tyrosine triplet (residues 755-757), phosphorylated by Met receptor and Src nonreceptor tyrosine kinases, is required for Hakai binding (Fujita et al., 2002) but is absent from Cad7 ( Figure 1a) . Therefore, Hakai is unlikely to bind Cad7, suggesting an alternative mechanism for the cell surface disassembly of this cad adhesion complex.
The b-catenin binding domain (BCBD), as defined by (Stappert and Kemler, 1994) , facilitates a mutually exclusive interaction with either b-catenin or plakoglobin. Sequence similarities between Cad7 and E-cad BCBD, 51% identity with no gaps (Figure 1a ), suggest that Cad7 presents a catenin docking site. The Cad7 BCBD contains eight of the nine serine residues of E-cad BCBD. These residues are potential kinase substrates and, when phosphorylated, enhance the integrity of the CCC.
The sequences of various mouse type II cadherin proteins were aligned with that of mouse Cad7 to assess overall relatedness (Figure 1b) . The molecules are all more than 50% identical, suggesting that they all have similar tertiary structures. The highest level of identity (61.4%) was that between Cad7 and Cad20. cdh20 was originally cloned as the mouse cdh7 ortholog (FaulknerJones et al., 1999) but was subsequently renamed . Known Cad7 orthologs are more than 90% identical (Figure 1c ) to mouse Cad7, with several stretches of about 70 amino acids displaying 100% identity. Cad20 orthologs also display significant, but lower levels of identity (Figure 1d ). The extensive similarity of the 5 0 and 3 0 UTRs of our clone to cdh7 cDNAs but not to cdh20 (data not shown) suggests that our clone is the bona fide mouse cdh7 ortholog. In the current study, we examined both cdh7 and cdh20 genes, considering interspecies identity, genomic structure and patterns of expression during embryogenesis and transformation.
Comparison of the structure of the mouse cdh7 gene with those of other type I and II cadherin genes Genome sequencing projects have partly determined the position of introns and exons in the cdh7 gene. The gene structure, and its relationship to the primary sequence of the Cad7 precursor protein are shown in Figure 2 . The genomic frameworks of cdh1 (type I), cdh5 and cdh20 (type II) are also given for comparison. The number of intron/exon boundaries differs between types I and II cadherin genes, for the EC1 (two and one, respectively), MPED (one and two) and CP (two and none) domains. The size of cadherin genes varies enormously. Excluding exon 1 and intron 1, cdh7 is about 90 kb in length. According to the definition given previously (Nollet et al., 2000) , we may classify cdh7 as a type II cadherin based on primary sequence and genomic structure.
Transcription of cdh7 and cdh20 in normal adult mouse organs
We used RT-PCR to assess the expression of cdh7 and cdh20 in various adult mouse tissues (Figure 3a -c). Transcripts for both cadherins were preferentially found in the brain. A weaker expression of cdh20 was also detected in the heart ( Figure 3b ) and a barely detectable cdh7 signal was detected in the lung by RT-PCR and Southern blotting (data not shown).
In situ hybridization (ISH) was performed on adult brain parasagittal sections, with probes hybridizing to cdh7, cdh20 and neurofilament (nf) light chain mRNA (Figure 3d-g ). Punctate hybridization was observed throughout the gray matter with antisense, but not with sense cadherin probes. The intensely stained spots were similar in size and not of vascular origin. In some cases, the boundary of layer IV cell somata hybridized with cdh7 and cdh20 probes so strongly that a purple outline of the cell was discernible, as observed for nf. In these specific cases, the pattern of hybridization was similar to nf, suggesting that, at least, some of the cdh7 and cdh20 detected was of neuronal origin. Punctate hybridization for cdh7 mRNA was clearly more abundant than that for cdh20 mRNA in the cortex. However, unlike cdh20 mRNA, cdh7 mRNA was exclusively located in the gray matter (data not shown).
cdh7 and cdh20 expression during murine embryogenesis
We used whole-mount ISH to investigate the spatiotemporal expression of cdh7 and cdh20 in C57BL/6 mouse embryos. We detected no cdh7 transcript at any gestational stage from E8.5 onwards. In contrast, cdh20 transcripts were abundant in anterior regions of the embryo from E8.5 to E11.5. After E12.5, cdh20 transcripts were no longer detected in the embryo. The hybridization pattern for cdh20 mRNA was always bilaterally symmetric and a disproportionate signal demarcated the anterior neuroectoderm, particularly at the extreme anterior end.
On E8.5, cdh20 was transcribed at three restricted sites along the longitudinal axis of the neural plate that had no apparent contact with each other: the anteriormost border of the neural plate and two transverse domains in the rudimentary cephalic folds (Figure 4a-c) . All cells of the anterior-most neuroepithelium, including the anterior neural ridge (ANR), contained a high amount of cdh20 transcripts. The most anterior transverse domain, located at the level of the prospective mesencephalon (pM), presented diffuse cdh20 hybridization, which was probably due to a mixing of cdh20-expressing and nonexpressing cells. In fact, hybridization appeared to be less diffuse at the midline. The posterior transverse domain demarcating the prospective posterior rhombencephalon (R) produced cdh20 transcripts. cdh20 was never expressed at the cranial neuroectoderm ridge or in the cranial neural crest, unlike cdh6 (Inoue et al., 1997) .
On E9.5, cdh20 continued to be expressed in the cephalic neuroectoderm ( Figure 5 ). At this point, cdh20 was expressed in the developing ophthalmic system (Figure 5a ). Both evaginating optic stalks (os) expressed cdh20 with no dorsal or ventral bias (Figure 5a ,c,e). However, the ectoderm directly facing the stalks was cdh20-negative. Very intense cdh20 hybridization was also detected in the intersecting lateral neuroectoderm and the ANR-derived prosencephalic commissural plate (cp) (Figure 5c ,e). The roof plate of the mesencephalon (M) was positive (Figure 5c, d, f) , and hybridization in the neuroepithelium tended to be reticulate and paramedial (Figure 5c,d) . However, upon sectioning the cdh20-positive cells were found to be mostly ventricular with cdh20-expressing and nonexpressing processes intermingling closer to the surface (Figure 5d,f) . Finally, in the most mature E9.5 specimens, the pretectum (pT) displayed hybridization (Figure 5a ). No signal was detected from the olfactory placodes.
On E10.5, the pattern of cdh20 transcription changed: the overt expression previously detected in the forebrain decreased, disappearing entirely in the most advanced E10.5 embryos. The pT displayed cdh20 transcription, as did the mesencephalon (M), (Figure 6a-c) . However, cdh20 transcription in the eye decreased, with cdh20 mRNA restricted to the ventral optic cup (voc) and was 
The intraspecific global identity of (b) Mus musculus (Mm) cad precursor proteins Cad6, Cad7, Cad11 and Cad20; (c) orthologous Cad7 precursor proteins and (d) Cad20 precursor proteins from chicken, human, Xenopus and mouse were determined by pairwise alignment. GenBank accession numbers of the selected Cad7 proteins: human ¼ Q9ULB5, rat ¼ XP_222491 and chicken ¼ AAL93123; and of the selected Cad20 proteins:
Cadherins in development and oncogenesis R Moore et al absent from the optic chiasma. During invasion of the cerebellar anlage (cer), the precursors of the cerebellar granule cells (originating from the lateral rhombic lips) produced Cdh20. NCC located in the most dorsal region synthesized Cdh20 (Figure 6d ). It is currently unclear whether this is characteristic of later-emerging NCC or of a subset of delaminated NCC such as melanoblasts, which appears more likely. cdh20 is expressed in a rostrocaudal gradient in a ventral location of the neural tube (vnt). This was observed on both whole mounts and transverse sections (Figure 6a and data not shown). The presomitic mesoderm (psm) in the tail bud expressed cdh20, with the hybridization being slightly more intense laterally than medially and the posterior part of the youngest somite (ys) (Figure 6e ). On Ell.5, cdh20 expression was very similar to that of the previous day except that the cdh20 riboprobe also hybridized to the sensory neurons of two adjacent cranial ganglia, the vestibulo-cochlear (VIIIth) and geniculate (VIIth) ganglia (Figure 6f,g ). The majority of cells comprising the ganglia were cdh20-positive, but heterogeneity was clear. Expression continued in the vnt, the psm in the tail and the ventral os and cup (Figure 6f and data not shown). The external granular layer of the cerebellar plates was clearly delineated by cdh20 expression, and it was clear that the number of hybridizing cells had increased since the previous day (Figure 6h ). This mosaic, 'sprinkly' pattern of expression continued in the midbrain.
The spatiotemporal pattern of cdh7 and cdh20 expression during embryogenesis was very similar in mice of C57BL/6 and 129/Sv backgrounds. However, in the 129/Sv background, we also detected strong expression in the newly formed myotome. With increasing age, the myotome and cdh20 hybridization progressively extended in a ventro-lateral direction (Figure 7 ). This transient expression was graded according to rostrocaudal location and was never detected with sense riboprobes. Thus, the regulation of cdh20 transcription may differ slightly in these two strains.
Expression of cdh7 and cdh20 in melanoma cell lines
Plasticity of cadherin expression is often observed during development and oncogenesis. Moreover, cadherins expressed during development are frequently reexpressed during transformation (Jouneau et al., 2000) . In this respect, 14 human melanoma and two human melanocyte cell lines were assayed by semiquantitative RT-PCR for CDH1, CDH2, CDH7 and CDH20 expression (Figure 8a-d) . Significant CDH1 expression was observed in both melanocyte lines and in four melanoma cell lines (Figure 8a ). CDH2 was expressed by 10 melanoma cell lines but not significantly in the two melanocyte lines and in four melanoma cell lines (Figure 8b ). These results are consistent with previous findings describing a mutually exclusive expression between these two cadherins. Interestingly, expression of CDH7 was detected in eight of 14 melanoma cell lines but not in the two melanocyte cell lines (Figure 8c ). Finally, CDH20 was not detected in most of the melanoma cell lines tested, and a very weak expression was detected in #2 cell line (Figure 8d ). Only one of 14 melanoma cell lines, #11, did not express CDH7 or CDH2 to a significant extent. Thus, the expression of CDH2 and CDH7 is correlated with the malignancy of human melanocytes.
Discussion
We present evidence for the identification and cloning of the mouse cdh7 ortholog. The encoded precursor protein is more than 90% identical to known orthologs, and the percent identity increases if the signal and prepeptides are excluded. Structural divergence of this gene and cadherin in general has therefore been very limited during evolution. Cad7 is most similar to Cad20 (61.4% identity), and the respective genes are linked on the long arm of human chromosome 18q22-23 and in a syntenic region of murine chromosome 1 (Faulkner-Jones et al., 1999 ). An alternatively spliced cdh7 cDNA has been isolated from chicken (Kawano et al., 2002) . This cDNA has a 49 bp insertion in the MPED, resulting in the production of a soluble Cad7. During screening, we never identified an alternative Cad7 isoform, suggesting that a soluble murine Cad7 may not actually be produced.
In adults, cdh7 and cdh20 are abundantly expressed in the brain. Similar profiles were observed for human tissues . Faulkner-Jones et al. (1999) also detected cdh20 expression in a subpopulation of ganglion cells in the adult retina that was not studied here. In Northern blot analysis of adult mouse brain mRNA, we detected several cdh7 mRNAs (data not shown). These three products may result from differences in polyadenylation or alternative splicing.
In embryos, the transcription of cdh20 is restricted to subregions of the brain, suggesting a role in compartmentalization (Redies, 1995) . Like many cadherins, cdh20 is predominantly expressed in the CNS. Proliferating external ganglion layer (egl) cells in the cerebellum 
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Cad7 b c d Figure 1 Continued may display Cad20-mediated adhesion. High levels of cdh20 transcription are observed in anterior territories of the neural plate, including the ANR, and in anterior aspects of the body axis. Notably, cdh20 is expressed in all pronuclei of the embryonic optical pathway, forming a generic Cad20-positive circuit. No Cad20-positive fiber tracts were observed, but interneuronal recognition, fasciculation and target selection may be regulated by chemoaffinity between a Cad20-positive growth cone and substrate. Cad20 production in the developing optic vesicles and pT resembles the expression patterns of Necab, Six3 and Pax6 on E9.5 and 10.5. Six3 and Pax6 are transcription factors and Pax6 has been shown to regulate Cad-dependent adhesive patterning in the CNS (Stoykova et al., 1997) and may participate in a network regulating cdh20 transcription. A subset of migrating neural crest cells transiently produced Cad20. They appeared to have recently emerged from the neural tube and their dorsolateral migration to the somite identifies them as future melanoblasts. No germ-line mutations in cadherin or catenin genes have been identified in pigmentation disorders. Furthermore, none of the four uncloned mouse coat color mutations (Vl, Dsu, Sea and Ge) on chromosome 1 map to either cdh20 or cdh7.
The patterns of expression of cdh7 and cdh20 in mouse embryos differ from those reported in other species. We detected no cdh7 expression in migrating NCC, equivalent to that occurring in chickens. Similarly, cdh20 expression patterns differed from those reported for cdh20 ( ¼ F-cad), in Xenopus (Espeseth et al., 1995) . Surprising though these observations appear, there is compelling evidence that cadherin gene expression patterns differ between species. Firstly, E-cad is produced in all epithelia of mouse and chicken embryos but is present in a subset of fasciculated sensory neurons only in mice (Shimamura et al., 1992) . Interspecies variation of expression is certainly not limited to cadherins. Expression patterns of the genes encoding Snail and Slug, transcription factors controlling cadherin production, differ in mice and chickens (Locascio et al., 2002) . Secondly, mouse Cad6 gene has a broader expression pattern than the chicken Cad6B gene, resembling a combination of the expression patterns for the chicken Cad6B and Cad7 genes (Inoue et al., 1997) . Thus in mouse, the function of Cad7 in NCC may be fulfilled by Cad6, accounting, at least in part, for the lack of Cad7 production in mouse NCC.
The pattern of cdh20 expression depended on the genetic background of the embryo. In embryos with the 129/Sv background, the cdh20 transcript was detected in the myotome. Assuming that cdh20 is 100% identical in different mouse strains, this difference must be due to an increase in expression or de novo transcription within the myotome of 129/Sv embryos. Classical geneticists showed in the 1950s the importance of genetic background and gene suppressors. More recently, authors have rediscovered this phenomenon. The best known example is certainly the epidermal growth factor receptor (EGFR) knockout, which presents very different phenotypes in different mouse strains. The general molecular mechanisms responsible for such differences are not clear but one of these molecular mechanisms may be associated with gene expression. This could be the case for cadherin-20. Furthermore, Cad20, possibly by increasing intercellular adhesion within an embryo, may modify (autonomously or not) a phenotype associated with the 129/Sv background. Altogether, mutation of cdh20 may induce myotome malformation in one genetic background but not in another. Such changes in expression may partly account for phenotypic variability observed between two different genetic backgrounds. Finally, cadherins have been implicated in the sorting of experimentally intermixed cell populations in vitro and in vivo (Nose et al., 1988) . Thus, it should be borne in mind that the differences detected in cdh20 expression may actually be due to cell movement and sorting rather than to quantitative changes in mRNA synthesis within individual cells.
The importance of markers in melanoma progression is certainly relevant to better diagnosis and prognosis of this type of tumor. CDH1 and CDH2 were used as markers of melanomas (Li and Herlyn, 2000) . However, they are not fully reliable. We tested a series of human melanoma cell lines for their ability to grow in nude mice. Interestingly, we could show that melanoma able to grow in nude mice were expressing CDH7 (data not shown). A better understanding of the role of CDH7 will be obtained once the question is addressed directly. In particular, among others, epigenetic repression of cad-7 will be important to perform to evaluate the role of this protein during tumor progression in vivo. In breast carcinoma, there is a switch from a type 1 cadherin (CDH1) to a type 1 and II cadherin (CDH2 and CDH11) (Feltes et al., 2002; Hazan et al., 2000) . We may imagine that a similar switch exists in melanoma Figure 4 In toto localization of cdh20 transcripts in the early neural tube of C57BL/6 mouse embryos. Whole-mount in situ hybridization of E8.5 mouse embryo with antisense cdh20 (a-c) and sense cdh20 (d) riboprobes. (a) Ventral, (b) lateral, and (c,d) dorsal views. cdh20 is transcribed in the anterior neuroepithelium, including the ANR. It is also expressed in the mesencephalon (pM) and the rhombencephalon (R), which are separated by the prospective isthmus (pIs) Figure 3 Expression profiles of cdh7 and cdh20 in adult mice (a-c) Analysis of cdh7 (a) and cdh20 (b) transcript abundance in adult male BALB/c mouse tissues. Primers LL257/LL258 were used for cdh7 amplification and LL239/LL240 for cdh20. The presence or absence of RT is indicated by þ /À. (c) HPRT, amplified using LL17/LL18, was used as an internal control. (d-g) In situ hybridization of adult brain sections from male 129/Sv mice with antisense (d) and sense cdh7 (e), antisense cdh20 (f) and antisense nf (g) probes. The arrows indicate the signal localized at the periphery of some cell bodies. The pial surface is at the top of the photomicrographs. The template used to synthesize cdh7 riboprobes was PCR.23. Scale bar: 250 mm Cadherins in development and oncogenesis R Moore et al but the type II cadherin would be CDH7. In this respect, according to these hypotheses, we believe that CDH7 should be extensively trialed in the future.
Materials and methods
Cloning of the murine cdh7 cDNA
The mouse cdh7 cDNA was cloned by a cross-species RT-PCR approach. The sequences of all primers used in this study are given in Table 1 as (Supplementary Information). Three pairs of primers-LL247 and LL248, LL261 and LL262, LL284 and LL285 -amplified fragments of 247, 267 and 443 bp from adult mouse brain RNA. These cDNAs (H3, 5C7.8 and 5PN.3) displayed high levels of identity, in terms of nucleotide and deduced amino-acid sequences, to chicken and human cdh7. Clones 5C7.8 and 5PN.3 were used independently to screen B1.2 Â 10 6 plaques of a male BALB/c mouse brain 5'-STRETCH PLUS cDNA library (Clontech Labs Inc., Palo Alto). The complete cdh7 cDNA sequence was generated by RT-PCR with the Expand High Fidelity PCR System (Roche Diagnostics GmbH, Mannheim), from DNAseI-treated BALB/c adult male mouse brain mRNA. Amino-acid sequences were aligned using CLUSTALW. Alignment shading was performed with BoxShade 3.21.
Whole-mount in situ hybridization of mouse embryos and sections
Timed pregnant mice were generated as follows: 129/Sv # 129/ Sv~, C57BL/6 # C57BL/6~or 129/Sv # FXVIII~. All mice were obtained from Iffa Credo (Charles River). Embryonic gene expression was analysed with nonradioactive singlestranded RNA probes. 11-Digoxigenin-UTP (DIG-UTP) was incorporated during synthesis (Roche Diagnostics GmbH, Mannheim). The entire cdh20 cDNA (Faulkner-Jones et al., 1999) was used as a transcription template. Cloning of the nf light chain probe has been reported elsewhere (Julien et al., 1986) . 5PN.3 (0.5 kb) was used as a cdh7 probe in wholeembryo hybridizations. Probes blc.5 (spanning cdh7 nucleotide Production of cdh20 mRNA on E10.5 and E11.5 in C57BL/6 mice embryos (a-e). E10.5 mouse embryos were hybridized with antisense cdh20 riboprobes. (a) Low-magnification lateral view demonstrating expression throughout the embryo. In the cephalic region, cdh20 is expressed in the os, pT, pM and cerplate. In the truncal region, emerging NCC and a ventral aspect of the vnt express cdh20. In the tail, the psm express cdh20. numbers 641-2137) and PCR.23 (nucleotide numbers 1061-2580) were used for transcript detection in the brain. Sense riboprobes derived from these cDNAs were used as negative controls.
Whole-mount in situ hybridization was performed as described by (Haenig et al., 2002) . Sheep anti-digoxigenin Fab fragments conjugated with alkaline phosphatase (Roche Diagnostics GmbH, Mannheim) were used for histochemical visualization, together with the chromogenic substrates BCIP/ NBT.
Adult brains from male 129/Sv or C57Bl/6 mice were embedded in gelatin and frozen in isopentane at -701C. ISH was performed on 20 mm sections as described above, except that the H 2 O 2 and proteinase K treatments were omitted.
RNA extraction and RT-PCR
Total cellular RNA was isolated from organs with the SV Total RNA Isolation System (Promega Corp, Madison). If poly(A) þ RNA was required, then the RNA recovered was used as the starting material for the QuickPrep mRNA Purification Kit (Apbiotech, UK).
Random-primed cDNA was synthesized from 1 mg of total RNA by reverse-transcription at 371C for 1 h in a 20 ml reaction mixture containing 500 nM of each dNTP, 200 U of RT (M-MLV, Gibco Life Tech Invitrogen), 300 mg/ml of random hexamer primers (Amersham Biotech), 40 U of RNase block (Promega), 1 Â first-strand buffer (Promega) and 10 mM of DTT. Reactions lacking RT served as negative controls.
Human melanoma cell lines were derived from tumor biopsies from patients with either primary or metastatic melanoma. The panel of melanoma cell lines studied included those generated by ourselves (#11), some kindly provided by B van den Eynde (#1, 2, 3, 4, 7, 8, 10, 12, 14) (LICR, Bruxelles), by R Baserga (#6) (Thomas Jefferson University, Philadelphia) and others purchased from the ATCC (#5,9,13). All were cultured in RPMI supplemented with 5 mM L-glutamine and 10% fetal #9  #10  #12  #11  #13  L  #14  P  #7  #4  #2  #8  #5  #1  #6  #3  #9  #10  #12  #11  #13  L  #14  P  #7  #4  #2  #8  #5  #1  #6  #3   #9  #10  #12  #11  #13  L  #14  P  #7  #4  #2  #8  #5  #1  #6  #3  #9  #10  #12  #11  #13  L  #14  P  #7  #4  #2  #8  #5  #1 #6 #3 a b c d Figure 8 Differential expression of cadherin genes in melanoma cell lines. The expression of E-cad (CDH1) (a), N-cad (CDH2) (b), CDH7 (c) and CDH20 (d) was followed by RT-PCR in fourteen melanomas (black) and in two melanocyte lines (gray) calf serum. We obtained RNA from L and P normal human primary melanocytes as gifts from J Jouanneau (Institut Curie, Paris) and from L Re´gnier (L'Ore´al). Real-time quantitative RT-PCR analyses for CDH1 (LL545 and LL546), CDH2 (LL547 and LL548), CDH7/cdh7 (LL537 and LL538), CDH20/cdh20 (LL541 and LL542) and TBP (LL521 and LL522) were performed in a Bio-Rad iCycler iQ Multi-Color Real-Time PCR Detection System. Each 25 ml reaction consisted of 2 ml of cDNA, 1x iQ SYBR Green Supermix (Bio-Rad) and 150, 600, 300, 300 or 300 nM of CDH1, CDH2, CDH7, CDH20 or TBP primers, respectively. The amount of the target transcript was related to that of a reference gene (TBP) by the Ct method. Each sample was assayed in triplicate.
